Contribution of BRCA1 and BRCA2 germline mutations to early onset breast cancer: a series from north of Morocco

被引：0
|
作者：
Joaira Bakkach
Mohamed Mansouri
Touria Derkaoui
Ali Loudiyi
ElMostafa El Fahime
Amina Barakat
Naima Ghailani Nourouti
Jaime Martinez De Villarreal
Carlos Cortijo Bringas
Mohcine Bennani Mechita
机构：
[1] University Abdelmalek Essaâdi,Biomedical Genomics and Oncogenetics Research Laboratory, Faculty of Sciences and Techniques of Tangier
[2] Oncology Clinic Al AMAL of Tangier,undefined
[3] Functional Genomic Plateform,undefined
[4] Units of Technical Support to Scientific Research,undefined
[5] National Center of Scientific and Technical Research,undefined
[6] Genetracer Biotech Laboratory,undefined
来源：
BMC Cancer | / 20卷
关键词：
Breast cancer; Young women; BRCA1; BRCA2; Germline mutations; Genetic testing; Morocco;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Germline BRCA1/BRCA2 mutations among high risk breast cancer patients in Jordan
    Abdel-Razeq, Hikmat
    Al-Omari, Amal
    Zahran, Farah
    Arun, Banu
    BMC CANCER, 2018, 18
  • [42] BRCA1 and BRCA2 mutations in breast cancer patients from Saudi Arabia
    El-Harith, EHA
    Abdel-Hadi, MS
    Steinmann, D
    Dork, T
    SAUDI MEDICAL JOURNAL, 2002, 23 (06) : 700 - 704
  • [43] Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Brazil
    Gomes, Magda C. B.
    Costa, Mauricio M.
    Borojevic, Radovan
    Monteiro, Alvaro N. A.
    Vieira, Roberto
    Koifman, Sergio
    Koifman, Rosalina Jorge
    Li, Song
    Royer, Robert
    Zhang, Shiyu
    Narod, Steven A.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 103 (03) : 349 - 353
  • [44] Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Cuba
    Rodriguez, Rolando Comacho
    Esperon, Antonio Alejandro
    Ropero, Ramon
    Rubio, Maria Caridad
    Rodriguez, Ronald
    Ortiz, Rosa M.
    Anta, Juan J. Lence
    de los Rios, Mario
    Carnesolta, Deyanira
    del Olivera, Maria C.
    Vansam, Somalia Stiu
    Royer, Robert
    Akbari, Mohammad R.
    Donenberg, Talia
    Narod, Steven A.
    FAMILIAL CANCER, 2008, 7 (03) : 275 - 279
  • [45] Clinical outcome and toxicity from taxanes in breast cancer patients with BRCA1 and BRCA2 pathogenic germline mutations
    Bayraktar, Soley
    Zhou, Jade Z.
    Bassett, Roland
    Barrera, Angelica M. Gutierrez
    Layman, Rachel M.
    Valero, Vicente
    Arun, Banu
    BREAST JOURNAL, 2020, 26 (08): : 1572 - 1582
  • [46] BRCA1 and BRCA2 mutations among breast cancer patients from the Philippines
    Matsuda, MLD
    Liede, A
    Kwan, E
    Mapua, CA
    Cutiongco, EMC
    Borg, ATÅ
    Narod, SA
    INTERNATIONAL JOURNAL OF CANCER, 2002, 98 (04) : 596 - 603
  • [47] Germline BRCA1 and BRCA2 mutations and the risk of bladder or kidney cancer in Poland
    Zlowocka-Perlowska, Elzbieta
    Toloczko-Grabarek, Aleksandra
    Narod, Steven A.
    Lubinski, Jan
    HEREDITARY CANCER IN CLINICAL PRACTICE, 2022, 20 (01)
  • [48] BRCA1 and BRCA2 Mutations in Women With Familial or Early-onset Breast/Ovarian Cancer in the Czech Republic
    Foretova, Lenka
    Machackova, Eva
    Navratilova, Marie
    Pavlu, Hana
    Hruba, Marcela
    Lukesova, Miroslava
    Valik, Dalibor
    HUMAN MUTATION, 2004, 23 (04) : 397 - 398
  • [49] Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Brazil
    Magda C. B. Gomes
    Mauricio M. Costa
    Radovan Borojevic
    Alvaro N. A. Monteiro
    Roberto Vieira
    Sergio Koifman
    Rosalina Jorge Koifman
    Song Li
    Robert Royer
    Shiyu Zhang
    Steven A. Narod
    Breast Cancer Research and Treatment, 2007, 103 : 349 - 353
  • [50] The spectrum of BRCA1 and BRCA2 mutations and clinicopathological characteristics in Chinese women with early-onset breast cancer
    Lili Chen
    Fangmeng Fu
    Meng Huang
    Jinxing Lv
    Wenzhe Zhang
    Chuan Wang
    Breast Cancer Research and Treatment, 2020, 180 : 759 - 766
12345